16 women from the university hospital and 14 women from the regional hospital were invited to participate. 11 women from the university hospital and 11 women from the regional hospital participated. | 22/30 (73%) |
When genetic testing was offered to the patient and by whom | Participants (n = 22) |
By surgeon before surgery | 8 (36.4%) |
By surgeon after surgery | 5 (22.7%) |
By oncologist during neo-adjuvant therapy | 4 (18.2%) |
By oncologist during adjuvant therapy | 3 (13.6%) |
During radiation treatment | 1 (4.5%) |
Could not remember | 1 (4.5%) |
Asked for the test themselves | 6 (27.3%) |
Time from diagnosis to interview | Range: 2–4 years (mean 3) |
Age at diagnosis | Range: 35–64 years (mean 48.7) |
Age at interview | Range: 38–66 years (mean 51.6) |
Results from genetic test | One positive for a BRCA2 pathogenic variant 21 normal test results |